Bio-Techne showcases innovative cancer research, cell therapy, and manufacturing tools at the AACR 2023 conference.

Minneapolis / PRNewswire / April 13, 2023 (local U.S. time)
Bio-Techne Corporation (NASDAQ:TECH) announced today the launch of a portfolio of products and solutions that advance cancer research and enable the development and manufacturing of cell and gene therapies at the American Association for Cancer Research (AACR) Annual Meeting. The AACR Annual Meeting will be held in Orlando, Florida from April 14 to 19.
At Bio-Techne's booth (#1763), a wide range of products, services, and technical capabilities will be showcased, including industry-leading reagents, immunoassays, proteomics analysis instruments, spatial biology solutions, and companion diagnostics for cancer research and exploration, the development of cell and gene therapies, and workflow solutions.
Additionally, several of our scientists will present the latest information on therapeutic biomarkers, structural and chemical biology, and spatial biology through posters.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related Links
Press Release